Valeant’s Disclosure: Why Now?

Of investors’ many concerns about Valeant Pharmaceuticals and its relationship with a specialty pharmacy, one has stood out: Why is Valeant talking about this only now? Until this week, Valeant’s disclosures on the subject were slim.


Vote on this story -->>>

Comments are closed.

this is a single

THE MIAMI METROPOLIS -your source for news, music, sports, movies, restaurants, reviews, weather, travel, arts, tech and events in Miami